Granitero 3 mg Injection 3 ml belongs to the class of 'anti-emetic' drugs, primarily used to treat nausea and vomiting caused by medical treatments after surgery or chemotherapy or radiation treatment for cancer. Nausea is defined as stomach discomfort and the sensation of an urge to vomit. Vomiting is the forcible voluntary or involuntary emptying of contents of the stomach through the mouth.

Granitero 3 mg Injection 3 ml contains an anti-emetic (eases vomiting symptoms) medicine, 'Granisetron', that belongs to the class of 5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers). It works by blocking the brain's serotonin (chemical messenger) activity that triggers nausea and vomiting during cancer treatment (chemotherapy or radiation therapy) or after surgery.

Granitero 3 mg Injection 3 ml will be administered by a healthcare professional; do not self-administer. Your doctor will decide the dose and duration based on the severity of your medical condition. Common side effects of Granitero 3 mg Injection 3 ml include diarrhoea, constipation, stomach pain, weakness, headache, fever, drowsiness, trouble sleeping, pain, redness, and swelling at the injection site. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

If you use other prescription or non-prescription medicines, inform your doctor before using Granitero 3 mg Injection 3 ml. Let your doctor know if you have any liver, kidney or heart diseases, stomach/intestinal problems, allergic reactions, and low levels of potassium and magnesium in the blood before starting Granitero 3 mg Injection 3 ml. This medicine may make you dizzy or drowsy; hence avoid driving or operating machinery if you are not mentally alert. Consult your doctor before using Granitero 3 mg Injection 3 ml if you are pregnant, planning for pregnancy or breastfeeding. Avoid consuming alcohol while being treated with Granitero 3 mg Injection 3 ml as it could lead to unwanted side effects. 

Granitero 3 mg Injection 3 ml contains an anti-emetic medicine, 'Granisetron', that treats nausea and vomiting caused due to cancer treatment (chemotherapy or radiation therapy) or after surgery. Granisetron belongs to the class of 5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers). When the cells lining the gastrointestinal tract are damaged by chemotherapy or radiation therapy, they release a natural substance called serotonin (5HT3, 5-hydroxytryptamine). This serotonin binds to serotonin receptors on nerves that induces nausea and vomiting. Granitero 3 mg Injection 3 ml works by blocking the brain's serotonin activity and preventing postoperative nausea and vomiting. 

Seeking medical advice if you use prescription or non-prescription medicines while being treated with Granitero 3 mg Injection 3 ml is suggested. Inform your doctor about a history of stomach/intestinal problems, heart diseases, electrolyte imbalance (potassium, sodium or calcium), and liver or kidney diseases before starting Granitero 3 mg Injection 3 ml. Please consult your doctor if you are pregnant or breastfeeding if the doctor advised you Granitero 3 mg Injection 3 ml. This medicine may make you feel dizzy, so drive or operate machinery only if you are alert. Avoid consuming alcohol during the course, as it could lead to increased dizziness. Granitero 3 mg Injection 3 ml is not recommended in children below two years of age.

• Let your doctor know you are taking Granitero 3 mg Injection 3 ml if you undergo medical tests.
• Heart function monitoring with an ECG or EKG (electrocardiogram) is recommended in heart patients since Granitero 3 mg Injection 3 ml may cause irregular heartbeat and QT prolongation (heart muscle takes longer than normal to recharge between beats).